Hang-Yu Zhou

Dr. Hang-Yu Zhou

Suzhou Institute of Systems Medicine, Suzhou, Anhui, China
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2022 in Journal of Medical Virology
Verified
Journal Article
Open access
MJMing‐Li Jiang
Ming‐Li Jiang
YXYan‐Peng Xu
Yan‐Peng Xu
HWHui Wu
Hui Wu
RZRu‐Nan Zhu
Ru‐Nan Zhu
YSYu Sun
Yu Sun
LZLinqing Zhao
Linqing Zhao
A series of nonpharmaceutical interventions (NPIs) was launched in Beijing, China, on January 24, 2020, to control coronavirus disease 2019. To reveal the roles of NPIs on the respiratory syncytial virus (RSV), respiratory specimens collected from children with acute respiratory tract infection between July 2017 and Dec 2021 in Beijing were screened by capillary electrophoresis‐based multiplex PCR (CEMP) assay. Specimens positive for RSV were subjected to a polymerase chain reaction (PCR) and genotyped by G gene sequencing and phylogenetic analysis using iqtree v1.6.12. The parallel and fixed (paraFix) mutations were analyzed with the R package sitePath. Clinical data were compared using SPSS 22.0 software. Before NPIs launched, each RSV endemic season started from October/November to February/March of the next year in Beijing. After that, the RSV positive rate abruptly dropped from 31.93% in January to 4.39% in February 2020; then, a dormant state with RSV positive rates ≤1% from March to September, a nearly dormant state in October (2.85%) and November (2.98%) and a delayed endemic season in 2020, and abnormal RSV positive rates remaining at approximately 10% in summer until September 2021 were detected. Finally, an endemic RSV season returned in October 2021. There was a game between Subtypes A and B, and RSV‐A replaced RSV‐B in July 2021 to become the dominant subtype. Six RSV‐A and eight RSV‐B paraFix mutations were identified on G. The percentage of severe pneumonia patients decreased to 40.51% after NPIs launched. NPIs launched in Beijing seriously interfered with the endemic season of RSV.

17 June 2023 in Cell Discovery
Verified
Journal Article
Open access
PDF file
XHXing-Yao Huang
Xing-Yao Huang
QCQi Chen
Qi Chen
MSMeng-Xu Sun
Meng-Xu Sun
HZHang-Yu Zhou
Hang-Yu Zhou
QYQing Ye
Qing Ye
CQCheng-Feng Qin
Cheng-Feng Qin
Virus spillover remains a major challenge to public health. A panel of SARS-CoV-2-related coronaviruses have been identified in pangolins, while the infectivity and pathogenicity of these pangolin-origin coronaviruses (pCoV) in humans remain largely unknown. Herein, we comprehensively characterized the infectivity and pathogenicity of a recent pCoV isolate (pCoV-GD01) in human cells and human tracheal epithelium organoids and established animal models in comparison with SARS-CoV-2. pCoV-GD01 showed similar infectivity to SARS-CoV-2 in human cells and organoids. Remarkably, intranasal inoculation of pCoV-GD01 caused severe lung pathological damage in hACE2 mice and could transmit among cocaged hamsters. Interestingly, in vitro neutralization assays and animal heterologous challenge experiments demonstrated that preexisting immunity induced by SARS-CoV-2 infection or vaccination was sufficient to provide at least partial cross-protection against pCoV-GD01 challenge. Our results provide direct evidence supporting pCoV-GD01 as a potential human pathogen and highlight the potential spillover risk.

25 April 2024 in Viruses
Verified
Journal Article
Open access
PDF file
HWHui Wu
Hui Wu
HZHang-Yu Zhou
Hang-Yu Zhou
ZHZheng Heng
Zheng Heng
AWAiping Wu
Aiping Wu
Viral co-infections, in which a host is infected with multiple viruses simultaneously, are common in the human population. Human viral co-infections can lead to complex interactions between the viruses and the host immune system, affecting the clinical outcome and posing challenges for treatment. Understanding the types, mechanisms, impacts, and identification methods of human viral co-infections is crucial for the prevention and control of viral diseases. In this review, we first introduce the significance of studying human viral co-infections and summarize the current research progress and gaps in this field. We then classify human viral co-infections into four types based on the pathogenic properties and species of the viruses involved. Next, we discuss the molecular mechanisms of viral co-infections, focusing on virus–virus interactions, host immune responses, and clinical manifestations. We also summarize the experimental and computational methods for the identification of viral co-infections, emphasizing the latest advances in high-throughput sequencing and bioinformatics approaches. Finally, we highlight the challenges and future directions in human viral co-infection research, aiming to provide new insights and strategies for the prevention, control, diagnosis, and treatment of viral diseases. This review provides a comprehensive overview of the current knowledge and future perspectives on human viral co-infections and underscores the need for interdisciplinary collaboration to address this complex and important topic.

1 April 2022 in Bioengineered
Verified
Journal Article
Open access
QLQiang Li
Qiang Li
HZHang-Yu Zhou
Hang-Yu Zhou
CWChuan Wang
Chuan Wang
ZZZhibin Zhu
Zhibin Zhu
Periodontitis is a chronic inflammation caused by the deposition of dental plaque on the tooth surface. Human periodontal ligament stem cells (hPDLSCs) have the potential of osteogenic differentiation. Long non-coding RNAs (lncRNAs) are collectively involved in periodontitis. This study was designed to explore the roles of Linc01133 in osteogenic differentiation of hPDLSCs. hPDLSCs obtained from the periodontal ligament (PDL) of patients with periodontitis were used to collect Linc01133, microRNA-30c (miR-30c), and bone gamma-carboxyglutamate protein (BGLAP) expression data, and their expression changes were traced during osteogenic differentiation of hPDLSCs. Quantitative reverse-transcription polymerase chain reaction as well as western blotting were used to analyze the levels of RNAs and proteins. Dual-luciferase reporter and RNA pull-down assays demonstrated the relationship between Linc01133, miR-30c, and BGLAP. Furthermore, alkaline phosphatase (ALP) staining and alizarin red staining were applied to evaluate the degree of osteogenic differentiation. Linc01133 was downregulated in the PDL of patients with periodontitis. Upregulated Linc01133 promoted osteogenic differentiation of hPDLSCs. Linc01133 could inhibit miR-30c expression by sponging miR-30c. miR-30c suppressed osteogenic differentiation. Additionally, miR-30c targeted BGLAP. Knockdown of BGLAP abrogated the effects of decreased miR-30c on osteogenic differentiation of hPDLSCs. Linc01133 acted as a ceRNA to regulate osteogenic differentiation of hPDLSCs via the miR-30c/BGLAP axis. Therefore, Linc01133 may participate in the progress of periodontitis. Graphical abstract

12 May 2023 in Viruses
Verified
Journal Article
Open access
PDF file
YCYexiao Cheng
Yexiao Cheng
CJChengyang Ji
Chengyang Ji
HZHang-Yu Zhou
Hang-Yu Zhou
ZHZheng Heng
Zheng Heng
AWAiping Wu
Aiping Wu
The SARS-CoV-2 genomic data continue to grow, providing valuable information for researchers and public health officials. Genomic analysis of these data sheds light on the transmission and evolution of the virus. To aid in SARS-CoV-2 genomic analysis, many web resources have been developed to store, collate, analyze, and visualize the genomic data. This review summarizes web resources used for the SARS-CoV-2 genomic epidemiology, covering data management and sharing, genomic annotation, analysis, and variant tracking. The challenges and further expectations for these web resources are also discussed. Finally, we highlight the importance and need for continued development and improvement of related web resources to effectively track the spread and understand the evolution of the virus.

1 January 2024 in The Innovation Medicine
Verified
Journal Article
Open access
PDF file
HZHang-Yu Zhou
Hang-Yu Zhou
YLYaling Li
Yaling Li
JLJia-Ying Li
Jia-Ying Li
JMJing Meng
Jing Meng
AWAiping Wu
Aiping Wu
The rapid emergence and global spread of infectious diseases pose significant challenges to public health. In recent years, artificial intelligence (AI) technologies have shown great potential in enhancing our ability to prevent, detect, and control infectious disease outbreaks. However, as a growing interdisciplinarity field, a gap exists between AI scientists and infectious disease biologists, limiting the full potential of AI in this field. This review provides a comprehensive overview of the applications of AI in infectious diseases, focusing on the progress along the four stages of outbreaks: pre-pandemic, early pandemic, pandemic, and periodic epidemic stages. We discuss AI methods in early detection and risk assessment, outbreak surveillance, diagnosis and control, and understanding pathogenic mechanisms. We also propose the primary limitations, challenges, and potential solutions associated with AI tools in public health contexts while examining crucial considerations for future enhanced implementation. By harnessing the power of AI, we can develop more precise and targeted strategies to mitigate the burden of infectious diseases and improve global health.